Yu Jo Chua

Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer

David Cunningham, William Allum, Sally Stenning et al. · New England Journal of Medicine · 2006 · 6.3K citations

Multicenter Randomized Phase II Clinical Trial Comparing Neoadjuvant Oxaliplatin, Capecitabine, and Preoperative Radiotherapy With or Without Cetuximab Followed by Total Mesorectal Excision in Patients With High-Risk Rectal Cancer (EXPERT-C)

Alice Dewdney, David Cunningham, Josep Tabernero et al. · Journal of Clinical Oncology · 2012 · 387 citations · Full text

Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial

Yu Jo Chua, Yolanda Barbáchano, David Cunningham et al. · The Lancet Oncology · 2010 · 319 citations

Neuro-oncology, Surgical Oncology, Radiation Therapy +11

Epirubicin, Oxaliplatin, and Capecitabine With or Without Panitumumab for Advanced Esophagogastric Cancer: Dose-Finding Study for the Prospective Multicenter, Randomized, Phase II/III REAL-3 Trial

Alicia Okines, S. Ashley, David Cunningham et al. · Journal of Clinical Oncology · 2010 · 129 citations

Adjuvant <i>nab</i> -Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial

Margaret A. Tempero, Uwe Pelzer, Eileen M. O’Reilly et al. · Journal of Clinical Oncology · 2022 · 120 citations · Full text